Innoviva, Inc. (HVE.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 09:13AM CEST. Market open.
| Previous Close | 14.00 |
| Open | 14.00 |
| Bid | 14.20 x 33200 |
| Ask | 14.50 x 32300 |
| Day's Range | 14.00 - 14.00 |
| 52 Week Range | 10.50 - 15.40 |
| Volume | |
| Avg. Volume | 1 |
| Market Cap | 897.891M |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 6.83 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 08, 2015 |
| 1y Target Est | N/A |
- Simply Wall St.
Should Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Innoviva's (NASDAQ:INVA) recent performance, when its stock has declined 10...
- GuruFocus.com
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
Company Sees 35% Year-Over-Year Growth in Q4 Product Revenues
- GuruFocus.com
Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition
Overview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of 4,144,447 shares in Innoviva Inc (NASDAQ:INVA). The transaction, which took place on December 29, 2023, reflects a 3.63% increase from the previous holding, marking a significant vote of confidence in the biopharmaceutical company. With a trade price of $16.04 per share, the firm has demonstrated a strategic move to capitalize on Innoviva's market potential.
© 2024 Yahoo. All rights reserved.